Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Carroll

Showing results (221-230 of 427) with videos related to

Pageof 43
Sort By:
Managed Care (Langhorne, Pa.)|March 26, 2008
Move to mandatory coverage wouldn't ensure universalityJohn Carroll
Biotechnology Healthcare|February 21, 2013
Global deals grow; so do regulatory issuesJohn Carroll
Biotechnology Healthcare|February 21, 2013
FDA keeps open mind about potential of surrogate endpointsJohn Carroll
Biotechnology Healthcare|February 21, 2013
Global stem cell industry growing, but can the u.s. Keep up?John Carroll
Biotechnology Healthcare|January 16, 2013
Where the wall will fall firstJohn Carroll
Biotechnology Healthcare|December 26, 2012
As REMS Requirements Simplify, Participants Need To Catch UpJohn Carroll
Biotechnology Healthcare|April 6, 2012
Money-Back Guarantees: Where Private Payers Might Not Wait for CMS To LeadJohn Carroll
Biotechnology Healthcare|April 6, 2012
The next generation: strong, specializedJohn Carroll
Biotechnology Healthcare|April 6, 2012
Peeling back the onionJohn Carroll
Biotechnology Healthcare|April 6, 2012
When a negative becomes a positive: GIC bucks the high-cost trendJohn Carroll
Pageof 43

Showing results (221-230 of 427) with videos related to

Sort By:
Pageof 43
Managed Care (Langhorne, Pa.)|March 26, 2008
Move to mandatory coverage wouldn't ensure universalityJohn Carroll
Biotechnology Healthcare|February 21, 2013
Global deals grow; so do regulatory issuesJohn Carroll
Biotechnology Healthcare|February 21, 2013
FDA keeps open mind about potential of surrogate endpointsJohn Carroll
Biotechnology Healthcare|February 21, 2013
Global stem cell industry growing, but can the u.s. Keep up?John Carroll
Biotechnology Healthcare|January 16, 2013
Where the wall will fall firstJohn Carroll
Biotechnology Healthcare|December 26, 2012
As REMS Requirements Simplify, Participants Need To Catch UpJohn Carroll
Biotechnology Healthcare|April 6, 2012
Money-Back Guarantees: Where Private Payers Might Not Wait for CMS To LeadJohn Carroll
Biotechnology Healthcare|April 6, 2012
The next generation: strong, specializedJohn Carroll
Biotechnology Healthcare|April 6, 2012
Peeling back the onionJohn Carroll
Biotechnology Healthcare|April 6, 2012
When a negative becomes a positive: GIC bucks the high-cost trendJohn Carroll
Pageof 43